A North Carolina pharmaceutical company is drawing heavy fire for refusing to supply a seven-year-old cancer survivor with an experimental new drug that could potentially save his life.
Josh Hardy has been battling various forms of cancer since he was only nine months old. Whether it was in his kidneys, thymus, lungs, or bone marrow, the boy managed to overcome the disease every time.
After a bone marrow transplant severely damaged what remained of his immune system, though, doctors discovered in February that a viral infection currently spreading through his body is putting his life in danger. As noted by CNN, he is currently in critical condition and vomits blood multiple times every hour.